Effect of the expression of DRαEβNOD molecule on the development of insulitis and diabetes in the non-obese diabetic (NOD) mouse

Clinical and Experimental Immunology

Volumn 103, Issue 1, 1996, Pages 141-148

  Yamane, K ^a   Yamamoto, K ^a   Yoshikawa, Y ^a   Sasazuki, T ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

DR transgenic mouse; E transgenic mouse; Glutamic acid decarboxylase; Insulitis; NOD mouse

Indexed keywords

AUTOANTIGEN; GLUTAMATE DECARBOXYLASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; INSULIN DEPENDENT DIABETES MELLITUS; INSULITIS; LYMPHOCYTE PROLIFERATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; TRANSGENIC MOUSE;

EID: 0029671122     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1996.00892.x     Document Type: Article

References (35)

1. Makino S, Kunimoto K, Muraoka Y et al. Breeding of a non-obese, diabetic strain of mice. Exp Anim 1980;29:1-13.
2. Kanazawa Y, Komeda K, Sata S et al. Non-obese-diabetic mice; immune mechanisms of pancreatic β-cell destruction. Diabetologia 1984;27:113-5.
3. Castano L, Eisenbath GS. Type 1 diabetes: a chronic autoimmune disease of human, mouse and rat. Annu Rev Immunol 1990;8:647-79.
4. Hattori M, Buse JB, Jackson RA et al. The NOD mouse: recessive diabetogenic gene in the major histocompatibility complex. Science 1986;231:733-5.
5. Acha-Orbea H, McDevitt HO. The first external domain of the nonobese diabetic mouse class II I-A β chain is unique. Proc Natl Acad Sci USA 1987;84:2435-9.
6. Nishimoto H, Kikutani H, Yamamura K et al. Prevention of autoimmune insulitis by expression of I-E molecules in NOD mice. Nature 1987;328:432-4.
7. k NOD transgenic mice. Int Immunol 1989;1:209-13.
8. Uno M, Miyazaki T, Uehira M et al. Complete prevention of diabetes in transgenic NOD mice expressing I-E molecules. Immunol Lett 1992;31:47-52.
9. Torben L, O'Reilly L, Hutchings P et al. Prevention of insulin-dependent diabetes mellitus in non-obese diabetic mice by transgenes encoding modified I-A β-chain or normal I-E α-chain. Nature 1990;345:727-9.
10. Fukui Y, Yamamoto K, Yokoyama N et al. Restricted expression of transgenic HLA-DRA gene in thymic epithelial cells and its roles in acquisition of T cell tolerance to self-superantigens and processed DRα-derived peptide. Bur J Immunol 1993;23:1678-86.
11. Fukui Y, Esaki Y, Kimura A et al. T-cell repertoire in a strain of transgcnic C57Bl/6 mice with the HLA-DRA gene on the X-chromosome. Immunogenetics 1993;37:204-11.
12. 0 mutant mice. Cell 1989;58:583-94.
13. d gene in C57Bl/6 transgenic mice. Nature 1985;316:67-69.
14. Prochazka M, Leiter EH, Serreze DV et al. Three recessive loci required for insulin-dependent diabetes in nonobese diabetic mice. Science 1987;237:286-9.
15. Todd JA, Aitman TJ, Cornall RJ et al. Genetic analysis of autoimmune type 1 diabetes mellilus in mice. Nature 1991;351:542-7.
16. Ghosh S, Palmer SM, Rodrigues NR et al. Polygenic control of autoimmune diabetes in nonobese diabetic mice. Nature Genetics 1993;4:404-9.
17. Silver LM, Artzt K, Barlow D et al. Mouse chromosome 17. Mammalian Genome 1992;3:5241-60.
18. Aitman TJ, Hearne CM, McAleer MA et al. Mononucleotide repeats are an abundant source of length variants in mouse genomic DNA. Mammalian Genome 1991;1:206-210.
19. Cornall RJ, Aitman TJ, Hearne CM et al. The generation of a library of PCR-analyzed microsatellite variants for genetic mapping of the mouse genome. Genomics 1991;10:874-81.
20. Nishi H, Kimura A, Harada H et al. Novel missense mutation in cardiac β myosin heavy chain gene found in a Japanese patient with hypertrophic cardiomyopathy. Biochem Biophys Res Commun 1992;188:379-87.
21. Fowlis GA, Adelman S, Knight AM et al. PCR-analyzed microsatellites of the mouse genome additional polymorphisms among ten inbred mouse strains. Mammalian Genome 1992;3:192-6.
22. Fukui Y, Nishimura Y, Iwanaga T et al. Glycosuria and insulitis in NOD mice expressing the HLA-DQw6 molecule. J Immunogenetics 1989;16:445-53.
23. Ozato K, Mayer N, Sachs DH. Hybridoma cell lines secreting monoclonal antibodies to mouse H-2 and Ia antigens. J Immunol 1980;124:533-40.
24. Wicker LS, Miller BJ, Coker LZ, et al. Genetic control of diabetes and insulitis in the nonobese diabetic (NOD) mouse. J Exp Med 1987;165:1639-54.
25. Kaufman DL, Clare-Salzler M, Tian J et al. Spontaneous loss of T-cell tolerance to glutumic acid decarboxylase in murine insulin-dependent diabetes. Nature 1993;366:69-72.
26. Dialynas DP, Wilde DB, Marrack P et al. Characterization of the murine antigenic determinant, designated L3T4a, recognized by monoclonal antibody GK 1-5: expression of L3T4a by functional T cell clones appears to correlate primarily with class II MHC antigen-reactivity. Immunol Rev 1983;74:29-56.
27. Ledbetter JA, Rouse RV, Micklem HS et al. T cell subsets defined by expression of Lyt-1,2,3 and Thy-1 antigens. J Exp Med 1980;152:280-95.
28. Lampson LA, Levy R. Two populations of Ia-like molecules on a human B cell line. J Immunol 1980;12:293-9.
29. Reich E-P, Sherwin RS, Kanagawa O et al. An explanation for the protective effect of the MHC class II I-E molecule in murine diabetes. Nature 1989;341:326-8.
30. Nakano N, Kikutani H, Nishimoto H et al. T cell receptor V gene usage of islet β cell-reactive T cells is not restricted in non-obese diabetic mice. J Exp Med 1991;173:1091-7.
31. β usage by the T cells which adoptively transfer diabetes in NOD mice. Eur J Immunol 1993;23:727-33.
32. Sarukhan A, Gombert J-M, Olivi M et al. Anchored polyrnerase chain reaction based analysis of the Vβ repertoire in the non-obese diabetic (NOD) mouse. Eur J Immunol 1994;24:1750-6.
33. Lipes MA, Rosenzweig A, Tan K-N et al. Progression to diabetes in nonobese diabetic (NOD) mice with transgenic T cell receptors. Science 1993;259:1165-9.
34. Katz JD, Wang B, Haskins K et al. Following a diabetogenic T cell from genesis through pathogenesis. Cell 1993;74:1089-100.
35. Deng H, Apple R, Michael CS et al. Determinant capture as a possible mechanism of protection afforded by major histocompatibility complex class II molecules in autoimmune disease. J Exp Med 1993;178:1675-80.